Panelists discuss how thoughtful sequencing of antipsychotics enhances adherence, safety, and long-term efficacy. Panelists discuss how first-generation antipsychotics primarily manage positive ...
A phase II trial found that the experimental antipsychotic LB-102 significantly reduced symptoms in hospitalized adults with acute schizophrenia compared to placebo, with a safety profile similar to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results